Received May 19, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 947985 | IM / LA |
Site: Itching at Injection Site-Mild, Additional Details: patient came to get heplisav vaccine. RPH administered Shringrix (NDC 58160-0823-11, Lot # 33FD3).